HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

Immunology

Volumn 101, Issue 2, 2000, Pages 191-200

  Kapasi, K ^a   Albert, S E ^b   Yie, S M ^a   Zavazava, N ^c   Librach, C L ^a,d  

^a Division of Reproductive Science   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF KIEL   (Germany)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HLA G ANTIGEN;

ALLOIMMUNITY; ARTICLE; CELL DIFFERENTIATION; CELL KILLING; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN TISSUE; MIXED LYMPHOCYTE CULTURE; PLACENTA; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE CULTURE TEST, MIXED; PLACENTA; PREGNANCY; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS;

EID: 0033779322     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00109.x     Document Type: Article

References (73)

1. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast
2. Heterogeneity of HLA-G genes identified by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCO)
3. Three new HLA-G alleles and their linkage disequilibria with HLA-A
4. Evidence for a polymorphism of HLA-G gene
5. Polymorphism of exon 3 of the HLA-G gene
6. Identification of a thymic epithelial cell subset sharing expression of the Class Ib HLA-G molecule with fetal trophoblasts
7. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line
8. A class I antigen, HLA-G, expressed in human trophoblasts
9. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts
10. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody
11. HLA-G expression during pre-implantation human embryo development
12. The human amnion is a site of MHC Class Ib expression: Evidence for the expression of HLA-E and HLA-G
13. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83+ dendritic cells expresses HLA-G as a membrane-bound and soluble protein
14. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
15. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
16. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation
17. Detection of soluble HLA-G molecules in plasma and amniotic fluid
18. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens
19. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
20. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4
21. Nonclassical HLA-G molecules are classical peptide presenters
22. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
23. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class I molecule on cytotrophoblasts
24. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells
25. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells
26. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
27. Human histocompatibility leukocyte antigen (HLA) -G molecules inhibit NKAT3 expressing Natural Killer cells
28. The CD94/NKG2-A inhibitory receptor complex is involved in Natural Killer cell-mediated recognition of cells expressing HLA-G1
29. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex
30. Recognition of human histocompatibility leukocyte antigen (HLA) -E complexed with HLA Class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
31. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
32. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself
33. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways
34. Fetal cells in maternal blood
35. Prenatal diagnosis using fetal cells from the maternal circulation
36. Fetal cells in maternal circulation: Progress in analysis of a rare event
37. T cell awareness of paternal alloantigens during pregnancy
38. + T-cells specific for paternal MHC class I accumulate during pregnancy
39. Th1-type immunity is incompatible with successful pregnancy
40. Maternal anti-placental cell-mediated reactivity and spontaneous abortions
41. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products
42. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens
43. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment
44. The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon
45. Purified truncated recombinant HLA-B7 molecules abrogate cell function in alloreactive cytotoxic T lymphocytes by apoptosis induction
46. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
47. HLA-G inhibits the allogeneic proliferative response
48. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
49. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses
50. Interaction of purified HLA class I molecules with alloreactive CTL
51. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
52. Biological activity of recombinant human IL-2 produced in Escherichia coli
53. Generation of NK cell activity from human bone marrow
54. Induction of proliferation in vitro of resting human natural killer cells. IL-2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells
55. + T cells
56. Shifts in the Th1/Th2 balance during human pregnancy correlate with apoptotic changes
57. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with pre-eclampsia
58. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe pre-eclampsia
59. Cytokine production by lymphocytes in pregnancy
60. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines
61. Selective activation of Th1- and Th2-type cells in vivo - Response to human collagen IV
62. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major
63. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model
64. + T cell differentiation
65. Regulation of the class of immune response induced by antigen. I. Specific T cells switch the in vivo response from a cell-mediated to humoral mode
66. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA) -G bind to peripheral blood myelomonocytic cells
67. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia
68. Expression of the non-classic histocompatibility antigen HLA-G by pre-eclamptic placenta
69. Altered expression of Human leukocyte antigen G (HLA-G) on extravillous trophoblasts in pre-eclampsia: Immunohistological demonstration with anti-HLA-G specific antibody '87G' and anti-cytokeratin antibody 'CAM5.2'
70. Increased release of tumor necrosis factor-α and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count
71. Evidence for an elevation in serum IL-2 and tumor necrosis factor-α levels before the clinical manifestations of pre-eclampsia
72. Effect of anti-hypertensive therapy in pre-eclampsia on levels of serum interleukin-4
73. A deficiency of placental IL-10 in preeclampsia